Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2012 Oct 19;37(4):589-91.
doi: 10.1016/j.immuni.2012.10.002.

Striking similarity: GATA-3 regulates ILC2 and Th2 cells

Affiliations
Comment

Striking similarity: GATA-3 regulates ILC2 and Th2 cells

Liang Zhou. Immunity. .

Abstract

Innate lymphoid cells (ILCs) and T helper (Th) cells share similar effector functions. In this issue of Immunity, Hoyler et al. (2012) and Mjosberg et al. (2012) demonstrate that GATA-3, a Th2 regulator, controls ILC2 differentiation, maintenance, and function.

PubMed Disclaimer

Figures

Figure 1
Figure 1. GATA-3 Is Essential for ILC2 Development and Function in Mice
GATA-3 determines the lineage specification of ILC2. GATA-3 is not only important for the maturation of ILC2P but also essential for the maintenance of ILC2P and mature ILC2. Bone marrow resident progenitors contain a population of cells that are LinSca1hiId2hi. These cells have high expression of GATA-3 and Id2 and show similar gene profile to mature ILC2, thus representing ILC2-specific progenitors (ILC2P). After adoptive transfer, ILC2P cells migrate to the gut preferentially and differentiate into functional ILC2 with production of effector cytokines (IL-13, IL-5, and IL-4), consistent with the expression of gut homing receptor CCR9. Mature ILC2 cells in the gut do not express α4β7 but upregulate KLRG1. ILC2 cytokines stimulate gut epithelial cells to produce protective factors (e.g., angiogenin and mucin) to control helminth infection.

Comment on

References

    1. Chang YJ, Kim HY, Albacker LA, Baumgarth N, McKenzie AN, Smith DE, Dekruyff RH, Umetsu DT. Nat. Immunol. 2011;12:631–638. - PMC - PubMed
    1. Halim TY, Maclaren A, Romanish MT, Gold MJ, McNagny KM, Takei F. Immunity. 2012;37:463–474. - PubMed
    1. Hoyler T, Klose CSN, Souabni A, Turqueti-Neves A, Pfeifer D, Rawlins EL, Voehringer D, Busslinger M, Diefenbach A. Immunity. 2012;37:634–648. this issue. - PMC - PubMed
    1. Mjosberg J, Bernink J, Golebski K, Karrich JJ, Peters CP, Blom B, te Velde AA, Fokkens WJ, van Drunen CM, Spits H. Immunity. 2012;37:649–659. - PubMed
    1. Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CG, Doering TA, Angelosanto JM, Laidlaw BJ, Yang CY, Sathaliyawala T, et al. Nat. Immunol. 2011;12:1045–1054. - PMC - PubMed